Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DaBlaCa-11: PDD in Flexible Cystoscopy
NCT02660190Phase 3Completed
- Start
- Feb 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hexaminolevulinate in bladder cancer. Started Feb 2016; status: completed.
02
Drugs
hexaminolevulinate
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT02660190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660190.